| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Director | Common Stock | 10.3K | $7.18K | $0.70 | Mar 26, 2025 | Direct |
| ATOSSA THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 125K | May 15, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ATOS | ATOSSA THERAPEUTICS, INC. | May 15, 2025 | 1 | $0 | 4 | May 16, 2025 | Director |
| ATOS | ATOSSA THERAPEUTICS, INC. | Mar 26, 2025 | 1 | $7K | 4 | Mar 28, 2025 | Director |
| ATOS | ATOSSA THERAPEUTICS, INC. | Jun 27, 2024 | 1 | $0 | 4 | Jul 1, 2024 | Director |
| ATOS | ATOSSA THERAPEUTICS, INC. | May 4, 2023 | 1 | $0 | 4 | May 5, 2023 | Director |
| ATOS | ATOSSA THERAPEUTICS, INC. | May 13, 2022 | 1 | $0 | 4 | May 16, 2022 | Director |
| ATOS | ATOSSA THERAPEUTICS, INC. | May 14, 2021 | 1 | $0 | 4 | May 18, 2021 | Director |